Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 27, 2023
Fluctuation of Anti-Domain 1 and Anti-β<sub>2</sub> -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies
Cecilia B Chighizola, Francesca Pregnolato, Danieli Andrade, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 12, 2023
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study
Elena Gkrouzman, Rohan Willis, Danieli Andrade, et al.
Frontiers in Immunology
|
June 11, 2026
Correction: Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohorts
Claudia Grossi, Caterina Bodio, Suresh Kumar, et al.
Frontiers in Immunology
|
May 18, 2026
Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohorts
Claudia Grossi, Caterina Bodio, Suresh Kumar, et al.
Frontiers in Immunology
|
April 27, 2026
Correction: A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry
Alexander Pine, Ayesha Butt, Laura Andreoli, et al.
Thrombosis Research
|
January 28, 2019
The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis
Savino Sciascia, Rohan Willis, Vittorio Pengo, et al.
Arthritis Care & Research
|
November 30, 2020
Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria
Medha Barbhaiya, Stephane Zuily, Yasaman Ahmadzadeh, et al.
The Journal of Rheumatology
|
December 1, 2020
Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository
Elena Gkrouzman, Ecem Sevim, Jackie Finik, et al.
Annals of the Rheumatic Diseases
|
November 22, 2025
Development and validation of a EULAR disease activity score in antiphospholipid syndrome
Maria G Tektonidou, Ricard Cervera, Angela Tincani, et al.
Current Rheumatology Reports
|
November 26, 2025
Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains
Medha Barbhaiya, Stephane Zuily, Mary-Carmen Amigo, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 27, 2023
Fluctuation of Anti-Domain 1 and Anti-β<sub>2</sub> -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies
Cecilia B Chighizola, Francesca Pregnolato, Danieli Andrade, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 12, 2023
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study
Elena Gkrouzman, Rohan Willis, Danieli Andrade, et al.
Frontiers in Immunology
|
June 11, 2026
Correction: Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohorts
Claudia Grossi, Caterina Bodio, Suresh Kumar, et al.
Frontiers in Immunology
|
May 18, 2026
Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohorts
Claudia Grossi, Caterina Bodio, Suresh Kumar, et al.
Frontiers in Immunology
|
April 27, 2026
Correction: A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry
Alexander Pine, Ayesha Butt, Laura Andreoli, et al.
Thrombosis Research
|
January 28, 2019
The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis
Savino Sciascia, Rohan Willis, Vittorio Pengo, et al.
Arthritis Care & Research
|
November 30, 2020
Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria
Medha Barbhaiya, Stephane Zuily, Yasaman Ahmadzadeh, et al.
The Journal of Rheumatology
|
December 1, 2020
Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository
Elena Gkrouzman, Ecem Sevim, Jackie Finik, et al.
Annals of the Rheumatic Diseases
|
November 22, 2025
Development and validation of a EULAR disease activity score in antiphospholipid syndrome
Maria G Tektonidou, Ricard Cervera, Angela Tincani, et al.
Current Rheumatology Reports
|
November 26, 2025
Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains
Medha Barbhaiya, Stephane Zuily, Mary-Carmen Amigo, et al.
Page
of 7